| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |